When liraglutide was acutely administered to bilaterally-adrenalectomized mice, NE levels in cecal contents tended to be increased and the expression of ClpB in cecal contents and NE levels in plasma were significantly increased (Fig
For individuals with diabetes, allulose appears to have minimal impact on blood glucose levels and does not require insulin dose adjustments in the way that regular sugars do
Therefore, the Food and Drug Administration (FDA) released a guidance requiring all new drugs for glycemic control in T2DM patients to demonstrate cardiovascular safety, a policy that was continued and further emphasized in the 2020 FDA Guidance for Diabetes Drug Development [7, 8]
Thompson GJ, Merritt MD, Pan WJ, Magnuson ME, Grooms JK, Jaeger D, et al
Cardiovascular Therapeutic, 2019 , 5164298